Cardiology
From the Journals
Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS
Patients who took rivaroxaban experienced almost two times as many thrombotic events as patients who took dose-adjusted vitamin K antagonists.
Conference Coverage
Novel cardiac troponin protocol rapidly rules out MI
PARIS – Three-quarters of patients who presented with suspected acute coronary syndrome were safely discharged from ED without hospital admission...
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
From the Journals
Heart disease raises risk of severe cutaneous adverse reactions to allopurinol
The study looked at allopurinol users over an 18-year period in British Columbia.
Conference Coverage
Skip supplemental O2 in nonhypoxic ACS
PARIS –
Video
Beta-blockers effective, safe for HFrEF with renal dysfunction
PARIS –
Conference Coverage
Machine learning–derived risk score predicts heart failure risk in diabetes patients
Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.
News
Early infusion of mononuclear cells may benefit stroke patients
Well-designed RCTs are needed to further assess safety and efficacy of the approach.
Conference Coverage
Remember that preeclampsia has a ‘fourth trimester’
Delivering the baby doesn’t always cure the hypertension.
From the Journals
Drug abuse–linked infective endocarditis spiking in U.S.
New cases doubled from 2002 to 2016, and those affected tended to be younger white males living in poverty.
Latest News
Milrinone beats dobutamine in extending survival in HF
PHILADELPHIA – Survival benefit favored milrinone regardless of indication for use in continuous outpatient intravenous inotropic therapy.